Kevin C. Gorman

2019

In 2019, Kevin C. Gorman earned a total compensation of $9.5M as Chief Executive Officer at Neurocrine Biosciences, a 9% increase compared to previous year.

Compensation breakdown

Bonus$667,000
Option Awards$6,000,525
Salary$725,000
Stock Awards$2,000,071
Other$58,230
Total$9,450,826

Gorman received $6M in option awards, accounting for 63% of the total pay in 2019.

Gorman also received $667K in bonus, $725K in salary, $2M in stock awards and $58.2K in other compensation.

Rankings

In 2019, Kevin C. Gorman's compensation ranked 823rd out of 13,971 executives tracked by ExecPay. In other words, Gorman earned more than 94.1% of executives.

ClassificationRankingPercentile
All
823
out of 13,971
94th
Division
Manufacturing
287
out of 5,701
95th
Major group
Chemicals And Allied Products
81
out of 2,200
96th
Industry group
Drugs
67
out of 1,886
96th
Industry
Biological Products, Except Diagnostic Substances
12
out of 389
97th

Pay ratio

Kevin C. Gorman's Pay$9,450,826
Median Employee's Pay$257,209
Pay Ratio

37

to 1

In 2019, the annual total compensation of Kevin C. Gorman was $9,450,826.

The annual total compensation of the median employee at Neurocrine Biosciences was $257,209.

The ratio of Kevin C. Gorman's pay to the pay of median employee was therefore 37 to one.

Source: SEC filing on April 9, 2020.

Gorman's colleagues

We found five more compensation records of executives who worked with Kevin C. Gorman at Neurocrine Biosciences in 2019.

2019

Matthew Abernethy

Neurocrine Biosciences

Chief Financial Officer

2019

Eric Benevich

Neurocrine Biosciences

Chief Commercial Officer

2019

Eiry Roberts

Neurocrine Biosciences

Chief Medical Officer

2019

Haig Bozigian

Neurocrine Biosciences

Chief Development Officer

2019

Kyle Gano

Neurocrine Biosciences

Chief Development and Strategy Officer

News

In-depth

You may also like